Lymphohematopoietic engineering using cas9 base editors
US-2025290101-A1 · Sep 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Webber Beau patents
Webber Beau is listed as an inventor on 39 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Webber Beau |
| Total patents | 39 |
| First publication | Mar 9, 2017 |
| Latest publication | Sep 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Lymphohematopoietic engineering using CAS9 base editors
US-12281327-B2 · Apr 22, 2025 · US
Intracellular genomic transplant and methods of therapy
US-11925664-B2 · Mar 12, 2024 · US
Intracellular genomic transplant and methods of therapy
US-11903966-B2 · Feb 20, 2024 · US
Delivery of molecules to cells using trogocytosis and engineered cells
US-2024042029-A1 · Feb 8, 2024 · US
Engineered immune cells for reagent delivery
US-2024026292-A1 · Jan 25, 2024 · US
Intracellular genomic transplant and methods of therapy
US-11642375-B2 · May 9, 2023 · US
Intracellular genomic transplant and methods of therapy
US-11642374-B2 · May 9, 2023 · US
Modified cells and methods of therapy
US-11583556-B2 · Feb 21, 2023 · US
Intracellular genomic transplant and methods of therapy
US-2022362297-A1 · Nov 17, 2022 · US
Recent patents
Latest publications not already listed above.
Genetically-edited immune cells and methods of therapy
US-2022282285-A1 · Sep 8, 2022 · US
Modified cells and methods of therapy
US-2022125843-A1 · Apr 28, 2022 · US
Tumor infiltrating lymphocytes and methods of therapy
US-2022105133-A1 · Apr 7, 2022 · US
Genetically modified gamma delta t cells and methods of making and using
US-2022088074-A1 · Mar 24, 2022 · US
Intracellular genomic transplant and methods of therapy
US-11266692-B2 · Mar 8, 2022 · US
Programmable nucleases and base editors for modifying nucleic acid duplexes
US-2022002717-A1 · Jan 6, 2022 · US
Tumor infiltrating lymphocytes and methods of therapy
US-11154574-B2 · Oct 26, 2021 · US
Modified cells and methods of therapy
US-11147837-B2 · Oct 19, 2021 · US
Modified cells and methods of therapy
US-2021260117-A1 · Aug 26, 2021 · US
Lymphohematopoietic engineering using cas9 base editors
US-2021040507-A1 · Feb 11, 2021 · US
Tumor infiltrating lymphocytes and methods of therapy
US-10912797-B2 · Feb 9, 2021 · US
Intracellular genomic transplant and methods of therapy
US-2020353001-A1 · Nov 12, 2020 · US
Tumor infiltrating lymphocytes and methods of therapy
US-2020330517-A1 · Oct 22, 2020 · US
Intracellular genomic transplant and methods of therapy
US-2020306310-A1 · Oct 1, 2020 · US
Intracellular genomic transplant and methods of therapy
US-2020306309-A1 · Oct 1, 2020 · US
Tumor infiltrating lymphocytes and methods of therapy
US-2020289570-A1 · Sep 17, 2020 · US
Tumor infiltrating lymphocytes and methods of therapy
US-2020289571-A1 · Sep 17, 2020 · US
Viral methods of making genetically modified cells
US-2019382799-A1 · Dec 19, 2019 · US
Viral methods of t cell therapy
US-2019374576-A1 · Dec 12, 2019 · US
Modified cells and methods of therapy
US-10406177-B2 · Sep 10, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Minnesota | 39 |
| Intima Bioscience Inc | 31 |
| Us Health | 22 |
| The Us Secretary Department Of Health And Human Services Office Of Technology Transfer National Inst | 1 |
| The U S A As Represented By The Sec Dep Of Health And Human Service | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K40/11 | 38 |
| C12N9/22 | 38 |
| C12N2310/20 | 38 |
| C12N5/0636 | 37 |
| C07K14/7051 | 35 |